These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24952301)

  • 1. Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.
    Ji L; Ni T; Shen Y; Xue Q; Liu Y; Chen B; Cui X; Lv L; Yu X; Cui Y; Lu X; Chen J; Mao G; Wang Y
    J Mol Histol; 2014 Oct; 45(5):573-82. PubMed ID: 24952301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of transformer 2β expression in prostate cancer.
    Diao Y; Wu D; Dai Z; Kang H; Wang Z; Wang X
    Int J Clin Exp Pathol; 2015; 8(6):6967-73. PubMed ID: 26261585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking down the expression of TRA2β inhibits the proliferation and migration of human glioma cells.
    Yang L; Tao T; Wang Y; Bao Z; He X; Cui G
    Pathol Res Pract; 2015 Oct; 211(10):731-9. PubMed ID: 26298634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ets1 and heat shock factor 1 regulate transcription of the Transformer 2β gene in human colon cancer cells.
    Kajita K; Kuwano Y; Kitamura N; Satake Y; Nishida K; Kurokawa K; Akaike Y; Honda M; Masuda K; Rokutan K
    J Gastroenterol; 2013 Nov; 48(11):1222-33. PubMed ID: 23361474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA.
    Kuwano Y; Nishida K; Kajita K; Satake Y; Akaike Y; Fujita K; Kano S; Masuda K; Rokutan K
    Cell Death Differ; 2015 May; 22(5):815-25. PubMed ID: 25342468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
    J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress-induced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells.
    Takeo K; Kawai T; Nishida K; Masuda K; Teshima-Kondo S; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C330-8. PubMed ID: 19439532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-335 inhibited cell proliferation of lung cancer cells by target Tra2β.
    Liu J; Bian T; Feng J; Qian L; Zhang J; Jiang D; Zhang Q; Li X; Liu Y; Shi J
    Cancer Sci; 2018 Feb; 109(2):289-296. PubMed ID: 29161765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC.
    Xue Q; Lv L; Wan C; Chen B; Li M; Ni T; Liu Y; Liu Y; Cong X; Zhou Y; Ni R; Mao G
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1539-49. PubMed ID: 23857189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.
    Ni T; Mao G; Xue Q; Liu Y; Chen B; Cui X; Lv L; Jia L; Wang Y; Ji L
    J Mol Histol; 2015 Oct; 46(4-5):325-35. PubMed ID: 26059795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
    Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
    J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
    Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
    Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HuR regulates alternative splicing of the TRA2β gene in human colon cancer cells under oxidative stress.
    Akaike Y; Masuda K; Kuwano Y; Nishida K; Kajita K; Kurokawa K; Satake Y; Shoda K; Imoto I; Rokutan K
    Mol Cell Biol; 2014 Aug; 34(15):2857-73. PubMed ID: 24865968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
    Yan J; Zhang D; Han Y; Wang Z; Ma C
    J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.